title: Tissue responses of calcium phosphate cement: a study in dogs.
abstract: The in vivo properties of a new kind of calcium phosphate cement were investigated in this study. Calcium phosphate cement was implanted as paste into femoral bone and dorsal muscle of dogs for 3 and 6 months, and as prehardened form into thigh muscles of dogs for 1, 2 and 6 months. Histology was performed on thin un-decalcified sections. No foreign body reaction, no inflammation and no necrosis were found both in bony site and in muscles. There was no connective tissue layer between the cement and bone when cement paste was implanted in the bone. A creeping substitution of cement by bone, in which osteoclast-like cells resorbed the cement as if the cement is a part of bone and new bone was formed directly on the resorption line of calcium phosphate cement, was found. Bone formation was found histomorphologically in pores and deep rugged surface of cement samples (both paste and prehardened form) implanted in muscles of dogs. The induced bone was also identified with backscattered scanning electron microscopy (BSE) and by energy-dispersive X-ray micro-analysis (EDX). The results suggest that the calcium phosphate cement used in this study is biocompatible, resorbable in a manner of creeping substitution, osteoconductive and osteoinductive. It seems that an ideal bone substitute can be developed by using this type of calcium phosphate cement.
authors.affiliation: Institute of Materials Science and Technology, Sichuan University, Chengdu, People's Republic of China. huipin.yuan@isotis.com
authors.forename: H
authors.initials: H
authors.lastname: Yuan
authors.forename: Y
authors.initials: Y
authors.lastname: Li
authors.forename: J D
authors.initials: JD
authors.lastname: de Bruijn
authors.forename: K
authors.initials: K
authors.lastname: de Groot
authors.forename: X
authors.initials: X
authors.lastname: Zhang
mesh_terms: D020341:Absorbable Implants; D000818:Animals; D001672:Biocompatible Materials / Q000009:adverse effects / Q000494:pharmacology*; D001843:Bone Cements / Q000009:adverse effects / Q000494:pharmacology*; D002130:Calcium Phosphates / Q000009:adverse effects / Q000494:pharmacology*; D004285:Dogs; D005269:Femur / Q000187:drug effects / Q000601:surgery; D008297:Male; D008422:Materials Testing; D008855:Microscopy, Electron, Scanning; D018482:Muscle, Skeletal / Q000187:drug effects / Q000601:surgery; D016348:Osseointegration; D019736:Prostheses and Implants
chemical_list: D001672:Biocompatible Materials; D001843:Bone Cements; D002130:Calcium Phosphates; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous